Recombinant Human Leukemia inhibitory factor protein (LIF) (Active)
Product Specifications
Background
LIF has the capacity to induce terminal differentiation in leukemic cells. Its activities include the induction of hematopoietic differentiation in normal and myeloid leukemia cells, the induction of neuronal cell differentiation, and the stimulation of acute-phase protein synthesis in hepatocytes.
Product Name Alternative
LIF, D factor, Melanoma-derived LPL inhibitor, MLPLI, Emfilermin
Gene ID
3976
UniProt
P15018
Target
SPLPITPVNA TCAIRHPCHN NLMNQIRSQL AQLNGSANAL FILYYTAQGE PFPNNLDKLC GPNVTDFPPF HANGTEKAKL VELYRIVVYL GTSLGNITRD QKILNPSALS LHSKLNATAD ILRGLLSNVL CRLCSKYHVG HVDVTYGPDT SGKDVFQKKK LGCQLLGKYK QIIAVLAQAF
Purification
>98% as determined by SDS-PAGE and HPLC.
Bioactivity
Fully biologically active when compared to standard. The ED50 as determined by the dose-dependent proliferation of human TF-1 cells is less than 0.1 ng, ml, corresponding to a specific activity of 1.0 107 IU, mg.
Storage Conditions
The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself. Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
Calculated Molecular Weight
19.7 kDa
Formulation
0.2 μ m filtered PBS, pH 7.4 , lyophilized
Host or Source
E.Coli
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog